Kronox Lab Sciences IPO, consisting solely of an offer for sale, presents potential for sustainable growth, with analysts recommending subscription. The issue, open until June 5, allocates 50% to QIBs, 15% to NIIs, and 35% to retail investors.
Subscribe To Our Free Newsletter |